Topic

Articles

Updates to general chapters on compounding, <795> Nonsterile Preparations and <797> Sterile Preparation, include requirements for equipment, cleaning, personnel garb, labeling, and surface contamination testing.

USP Revises Drug Compounding Chapters

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

A possible change in leadership on Capitol Hill has aggravated fears of political push-back on FDA regulation and approval of contraceptives and other medications.

FDA Embroiled in Reproductive Rights Debate

AstraZeneca’s Imjudo (tremelimumab) was approved by FDA in combination with Imfinzi (durvalumab) for treating unresectable liver cancer.

FDA Approves AstraZeneca’s Imjudo for Combination Liver Cancer Treatment

An advisory committee’s vote to remove Makena from the market illustrates how difficult it is for regulators to ensure that such drugs document safety and effectiveness in a timely manner.

Pressure Mounts for FDA to Reform Accelerated Approval Program

South Africa’s vaccine regulator has reached new WHO level to ensure safety, quality, and effectiveness.

WHO Ranks South Africa’s Vaccine Regulatory System at a Functional Level of Maturity

The agency has recommended approval of Comirnaty and Spikevax for children from six months of age.

EMA Extends Use of COVID-19 Vaccines to Children

The agency has recommended authorization of the Spikevax COVID-19 vaccine that targets the Omicron variants BA.4 and BA.5.

EMA Recommends Adapted Spikevax Vaccine

Ebvallo (tabelecleucel) would be the first EMA-approved therapy for patients with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease.

Post-Transplant Lymphoproliferative Disease Treatment Receives Marketing Authorization Recommendation from EMA

Takeda’s dengue vaccine is designed to prevent disease caused by virus serotypes 1, 2, 3, and 4 in individuals four and older.

EMA Announces Positive Indication for Takeda’s Dengue Vaccine

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Podcasts

In this episode, Ana Ladino provides expert insight into novel excipients in the current and future drug development landscape.

Quality Systems